Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioNTech SE - American Depositary Shares (NQ:BNTX)

80.23 -21.92 (-21.46%)
Streaming Delayed Price Updated: 10:16 AM EDT, Mar 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about BioNTech SE - American Depositary Shares

< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
72 73 Next >
News headline image
Moderna Asks FDA To Sign Off On Its Updated Covid Booster Shot ↗
Moderna put the finishing touches on its FDA filing Tuesday, trailing its rivals by a day. 
Via Investor's Business Daily
News headline image
Pfizer/BioNTech's COVID-19 Vaccine Updated Data Shows Around 76% Efficacy In Toddlers ↗
Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) have  
Via Benzinga
News headline image
Pfizer and BioNTech Announce Updated COVID-19 Vaccine Data Supporting Efficacy in Children 6 Months through 4 Years of Age
From Pfizer Inc.
Via Business Wire
News headline image
BioNTech Whale Trades For August 09 ↗
  A whale with a lot of money to spend has taken a noticeably bullish stance on BioNTech. Looking at options history for BioNTech (NASDAQ:BNTX) we detected 10 strange trades. 
Via Benzinga
News headline image
Why Is BioNTech (BNTX) Stock Down 7% Today? ↗
BioNTech (BNTX) stock is on falling on Monday after the company released poor earnings results for its second quarter of 2022. 
Via InvestorPlace
News headline image
Recap Of Monday's Biotech Catalysts - End Of the Day Summary ↗
 
Via Benzinga
News headline image
Boosters Are Coming For Dangerous Omicron COVID-19 Variant. Here's Who May Be Rolling Them Out ↗
 
Via Benzinga
News headline image
Face Of US COVID-19 Response, Dr Anthony Fauci To Retire In December ↗
  
Via Benzinga
News headline image
Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine
From Pfizer Inc.
Via Business Wire
News headline image
Benzinga Before The Bell: Apple Employees Resist Calls For Return-To-Office, Tesla About To Hike FSD Prices Again, MGM China Injects $594M Into Macau Unit And Other Top Financial Stories Monday, August 22 ↗
Reuters Vodafone To Sell Hungarian Business For $1.8B: Report 
Via Benzinga
News headline image
Canada OKs Pfizer COVID-19 Booster For Kids Aged 5-11 Years ↗
 
Via Benzinga
News headline image
Covid Stocks Pfizer, Moderna, Novavax Face Their Next Challenge, And It's Worth Billions ↗
How they handle an upcoming shift in payments will be telling for their tailwind. 
Via Investor's Business Daily
News headline image
Biden Administration To Stop Purchasing COVID-19 Solutions By End Of 2022 ↗
 
Via Benzinga
News headline image
7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher ↗
These monkeypox stocks could be among the best choices to buy in August. Each can make great investments as government responses ramp up. 
Via InvestorPlace
News headline image
A Look Into Healthcare Sector Value Stocks ↗
  Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base... 
Via Benzinga
News headline image
Landmark Drug Pricing Reform Bill Passes Congress House ↗
The U.S. House of Representatives voted 220-207 to pass new, wide-ranging legislation allowing Medicare drug price negotiations for the first time and capping seniors’ drug expenses to $2,000 per year... 
Via Benzinga
News headline image
Stock Market Rally Rises On Inflation Data; Nvidia, Micron, Tesla, Disney In Focus: Weekly Review ↗
The major indexes continued to advance, despite some key warnings. 
Via Investor's Business Daily
News headline image
Pharmaceutical Companies Report Gearing Up To Combat COVID Variants This Fall ↗
The more contagious omicron BA.4 and BA.5 COVID-19 variants are dominant in all parts of the United States, making up more than 70% of infections.  
Via Benzinga
Global Multiple Sclerosis Drugs Market Size Projected To Reach $33 Billion By 2029
Palm Beach, FL –– August 11, 2022 – FinancialNewsMedia.com News Commentary – Multiple Sclerosis (MS) is an immune-mediated disease affecting the central nervous system. It is characterized by... 
Via FinancialNewsMedia
News headline image
Twitter To $50? Here Are 5 Other Price Target Changes For Wednesday ↗
Wedbush boosted the price target on Twitter, Inc. (NYSE: TWTR) from $30 to $50. Wedbush analyst Daniel Ives maintained the stock with a Neutral rating. Twitter shares rose 3.4% to $44.29 in pre-market... 
Via Benzinga
News headline image
7 Blue-Chip Stocks That Will Survive 2022 ↗
These are among the best blue-chip stocks to buy now. Here's why ABBV, BDX, CI, DD, MMM, JPM, and PFE can make great investments. 
Via InvestorPlace
News headline image
Fear & Greed Index Remains In 'Neutral' Zone As Investors Await Wednesday's Inflation Report ↗
The U.S. stock markets remained in the "neutral" zone on Tuesday, according to the CNN Money Fear and Greed index. Wall Street closed mixed on Friday after a New York Federal Reserve survey showed U.S.... 
Via Benzinga
News headline image
Here's What's Going On With Novavax Shares ↗
Novavax, Inc. (NASDAQ: NVAX) shares are trading lower by 3.05% to $58.43 Monday afternoon in sympathy with BioNTech SE - ADR (NASDAQ: BNTX), which reported worse-than-expected second-quarter results. 
Via Benzinga
News headline image
Why Moderna Shares Are Falling Following BioNTech's Earnings Results ↗
Moderna Inc (NASDAQ: MRNA) shares are trading lower by 2.32% to $182.50 Monday afternoon in sympathy with BioNTech SE - ADR (NASDAQ: BNTX), which reported worse-than-expected second-quarter results. 
Via Benzinga
News headline image
Why These Pfizer Analysts Like The Global Blood Therapeutics Deal ↗
Pfizer Inc. (NYSE: PFE) shares were trading lower Monday after the drugmaker announced a $5.4-billion bid to acquire blood disorder drugmaker Global Blood Therapeutics Inc (NASDAQ: GBT). 
Via Benzinga
News headline image
Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday ↗
Gainers Helbiz, Inc. (NASDAQ: HLBZ) jumped 114.6% to close at $1.61 on Monday after climbing over 27% on Friday. 
Via Benzinga
News headline image
Equity Index Futures Slightly Higher As U.S. Dollar Retreats ↗
(Monday Market Open) Equity index futures pointed to a higher open as the U.S. dollar retreated from Friday’s rally. 
Via Benzinga
News headline image
Why CinCor Pharma Is Trading Higher By 63%, Here Are 79 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Bonso Electronics International Inc. (NASDAQ: BNSO) shares jumped 132% to $11.12 after jumping around 46% on Friday. The company recently said it expects unaudited comprehensive loss of $1.6... 
Via Benzinga
News headline image
NVIDIA, Tyson Foods, BioNTech And Some Other Big Stocks Moving Lower On Monday ↗
  AMTD Digital Inc. (NYSE: HKD) dipped 21.8% to $563.71 on possible profit taking after the stock surged over the last few trading days. 
Via Benzinga
News headline image
Karuna Therapeutics (KRTX) Stock Soars 64% on Positive Clinical Data ↗
Karuna Therapeutics (KRTX) stock is rocketing higher on Monday thanks to results from a Phase 3 EMERGENT-2 trial to treat schizophrenia. 
Via InvestorPlace
< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
72 73 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.